KVUE · 10-Q · 2026Q3

Kenvue Inc.

Filed 2026-10-30 · Industrials · View original filing on EDGAR

Everything KVUE's SEC filings said, ranked

Ranked Events

• Acquisition / Partnership / DivestitureImportance 76 · Surprise 60
  Kenvue and Kimberly-Clark entered into a merger agreement under which K-C will acquire all outstanding Kenvue shares for 0.14625 K-C shares and $3.50 in cash per Kenvue share. Upon completion, Kenvue shareholders are…
• Senior Notes Exchange OfferImportance 74 · Surprise 42
  On September 28, 2026, K-C commenced offers to exchange Kenvue’s Senior Notes for up to $7.0 billion aggregate principal amount of new K-C notes and cash. Kenvue also solicited consents to amend the Senior Notes…
• Restructuring Program ChargesImportance 58 · Surprise 42
  On February 17, 2026, Kenvue’s Board approved the 2026 Restructuring Initiative to optimize its operating model, transform its supply chain, reduce complexity, and strengthen core capabilities. The company expects…
• Operating Cash Flow TrendsImportance 52 · Surprise 56
  Net cash from operating activities increased $534 million, or 39.8%, to $1,877 million for the fiscal nine months ended September 27, 2026, from $1,343 million in the comparable 2025 period. The increase reflected $225…
• Senior Notes RedemptionImportance 48 · Surprise 42
  On February 13, 2026, Kenvue notified holders of the planned full redemption of its 5.35% Senior Notes due 2026. The company redeemed all $750 million aggregate principal amount outstanding on February 23, 2026, at par…
• Segment ProfitabilityImportance 46 · Surprise 56
  Self Care adjusted operating income increased $61 million, or 3.8%, to $1,674 million for the fiscal nine months ended September 27, 2026, driven by value realization and supply-chain optimization benefits, partly…
• Dividend DeclarationImportance 42 · Surprise 14
  Kenvue paid $1,199 million of dividends during the fiscal nine months ended September 27, 2026. The company declared per-share dividends of $0.2075 in January and April 2026 and $0.21 in July 2026. On September 10,…
• Liquidity and Debt PositionImportance 37 · Surprise 6
  As of September 27, 2026, Kenvue held $1,039 million in cash and cash equivalents and had $8,206 million of total debt. Debt included $6,942 million of Senior Notes, net of $58 million in discounts and issuance costs,…
• Market Demand TrendsImportance 37 · Surprise 32
  Kenvue’s net sales increased 3.2% to $3.886 billion in the fiscal quarter, with organic sales up 2.9% on 1.6% volume growth and 1.3% favorable price/mix. Self Care organic sales rose 5.4%, led by Pain Care and Cough…
• Revenue Performance and MixImportance 37 · Surprise 32
  For the nine months ended September 27, 2026, net sales increased 3.6% to $11.750 billion from $11.344 billion, including 1.9% favorable foreign currency impact and 1.7% organic growth. Organic growth comprised 1.0%…
• Income Tax Rate ChangesImportance 35 · Surprise 48
  For the nine months ended September 27, 2026, tax provision increased $87 million to $519 million, up 20.1%, primarily because of higher year-to-date pretax income and fewer favorable U.S. return-to-provision…
• U.S. Tax Law ChangesImportance 34 · Surprise 42
  Kenvue says the One Big Beautiful Bill Act, enacted in the prior year, became effective in the current year and affected U.S. tax on foreign earnings. Related regulatory guidance was issued during the fiscal three…
• Middle East Conflict ImpactImportance 32 · Surprise 24
  Kenvue reports that the conflict in the Middle East has caused volatility in the cost or availability of raw materials, commodities, logistics, transportation and other product inputs. For the nine months ended…
• Competition and Market ShareImportance 27 · Surprise 32
  Skin Health and Beauty organic sales declined 0.5% in the quarter, with volume down 1.7%. Distribution losses and the timing of U.S. promotions, together with retailer price negotiations in Europe, were the primary…
• Gross Margin DriversImportance 25 · Surprise 14
  For the nine months ended September 27, 2026, gross profit margin expanded 20 basis points to 58.9% from 58.7%, while cost of sales increased 3.1% to $4.833 billion. Supply chain optimization benefits and favorable…
• Product Launch and TransitionImportance 23 · Surprise 24
  Product innovation contributed to demand across Kenvue’s consumer health portfolio. In Self Care, Digestive Health benefited from product innovation and e-commerce growth in the United States. In Essential Health,…
• Inflation, Tariffs and FXImportance 20 · Surprise 24
  For the nine months ended September 27, 2026, Kenvue cited net input cost inflation, unfavorable foreign-currency movements, and the impact of the conflict in the Middle East as offsets to adjusted operating income…
• Distribution Gains in Wound CareImportance 20 · Surprise 24
  In the Essential Health Segment, e-commerce performance, Baby Care distribution gains, and product innovation—primarily in Baby Care and Wound Care—supported volume growth. Oral Care volume declined, largely due to…
• Products and TechnologyImportance 20 · Surprise 24
  The Skin Health and Beauty Segment recorded volume-related growth, supported by strong e-commerce performance and product innovation across major need states, primarily in North America and EMEA. Hair regrowth products…
• Operating Expense TrendsImportance 20 · Surprise 14
  For the nine months ended September 27, 2026, selling, general, and administrative expenses were $4.559 billion, up $6 million, or 0.1%, while SG&A declined to 38.8% of sales from 40.1%. Higher Pending Transaction…

Revenue by Product (in millions)